4.6 Article

Impact of myeloid RIPK1 gene deletion on atherogenesis in ApoE-deficient mice

Journal

ATHEROSCLEROSIS
Volume 322, Issue -, Pages 51-60

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2021.02.021

Keywords

Atherosclerosis; Necroptosis; RIPK1; Apoptosis

Funding

  1. Fund for Scientific Research (FWO)Flanders [EOS 30826052]
  2. EOS MODEL-IDI [30826052]
  3. FWO research grant [G.0E04.16N, G.0C76.18N, G.0B71.18N, G.0B96.20N]
  4. Methusalem [BOF16/MET_V/007]
  5. Belgian Foundation against Cancer [FAF-F/2016/865]
  6. Cancer Research Institute Ghent (CRIG)
  7. Ghent Gut Inflammation Group (GGIG)
  8. VIB (Vlaams Instituut voor Biotechnologie)

Ask authors/readers for more resources

Myeloid-specific RIPK1 gene deletion can reduce plaque formation and necrotic cell numbers, slowing down the progression of atherosclerosis. However, over time, the accumulation of free apoptotic and necrotic cells may result in an increase in plaque and necrotic core size.
Background and aims: Targeting macrophage death is a promising strategy for stabilizing atherosclerotic plaques. Recently, necroptosis was identified as a form of regulated necrosis in atherosclerosis. Receptor-interacting serine/threonine-protein kinase (RIPK)1 is an upstream regulator of RIPK3, which is a crucial kinase for necroptosis induction. We aimed to investigate the impact of myeloid-specific RIPK1 gene deletion on atherogenesis. Methods: RIPK1(F/F)LysM-Cre(+)ApoE(-/-) and RIPK1(+/+)LysM-Cre(+)ApoE(-/-) mice were fed a western-type diet (WD) for 16 or 24 weeks to induce plaque formation. Results: After 16 weeks WD, plaque area and percentage necrosis in RIPK1(F/F)LysM-Cre(+)ApoE(-/-) mice were significantly decreased as compared to plaques of RIPK1(+/+)LysM-Cre(+)ApoE(-/-) mice. Moreover, plaques of RIPK1(F/F)LysM-Cre(+)ApoE(-/-) mice showed more apoptosis and a decreased macrophage content. After 24 weeks WD, plaque size and percentage necrosis were no longer different between the two groups. Free apoptotic cells strongly accumulated in plaques of RIPK1(F/F)LysM-Cre(+)ApoE(-/-) mice. In addition to apoptosis, necroptosis was upregulated in plaques of RIPK1(F/F)LysM-Cre(+)ApoE(-/-) mice. In vitro, TNF-alpha triggered apoptosis in RIPK1(F/F)LysM-Cre(+)ApoE(-/-), but not in RIPK1(+/+)LysM-Cre(+)ApoE(-/-) macrophages. Moreover, RIPK1(F/F)LysM-Cre(+)ApoE(-/-) macrophages were not protected against RIPK3-dependent necroptosis Conclusions: The impact of myeloid RIPK1 gene deletion depends on the stage of atherogenesis. At 16 weeks WD, myeloid RIPK1 gene deletion resulted in increased apoptosis, thereby slowing down plaque progression. However, despite decreased macrophage content, plaque and necrotic core size were no longer reduced after 24 weeks of WD, most likely due to the accumulation of free apoptotic and necroptotic cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available